Revelation Biosciences
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $26 |
Gross Profit | -7 | -7 | 13 | |
EBITDA | -1,900 | -2,454 | -2,087 | -1,746 |
EBIT | -1,907 | -2,461 | -2,094 | -1,753 |
Net Income | -1,907 | -2,444 | -2,051 | -1,725 |
Net Change In Cash | 0 | 0 | 0 | 26 |
Free Cash Flow | -1,588 | -1,919 | -2,794 | -3,729 |
Cash | 12,708 | 5,173 | 3,704 | 6,499 |
Basic Shares | 2,644 | 802 | 971 | 346 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -27 | -25 | -40 | -69 |
EBITDA | -7,947 | -8,631 | -10,839 | -11,933 |
EBIT | -7,975 | -8,656 | -10,864 | -11,950 |
Net Income | -15,038 | -120 | -10,829 | -11,986 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -18,340 | -7,286 | -11,219 | -11,222 |
Cash | 6,499 | 11,991 | 5,252 | 1,274 |
Basic Shares | 171 | 14 | 17 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$1.77 |
2025-06-30 | -$7.01 |
2025-03-31 | -$2.11 |
2024-12-31 | -$4.98 |
